{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:20:25Z","timestamp":1789402825182,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Extreme immature infants are at an increased risk of fungal infection due to immaturity of the skin barrier and the immune system. Besides Candida infections, in particular, Aspergillus may cause life-threatening diseases in preterm infants. Frequently, Aspergillus primarily affects the skin and may cause extensive damage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched our hospital database for fungal infections other than Candida in preterm infants treated between 2015 and 2020 at our level III neonatal intensive care unit of the University Hospital of Cologne.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 13 preterm infants were identified. Of these, 11 had cutaneous Aspergillosis, one infant had severe enterocolitis caused by Aspergillus and Rhizopus and one had invasive intraabdominal <jats:italic toggle=\"yes\">Trichosporon mucoides<\/jats:italic> infection. All infants were born &lt;24 weeks of gestation, were delivered due to premature labor or chorioamnionitis, and had received prenatal steroids and\/or hydrocortisone. Voriconazole and liposomal Amphotericin B were first-line treatments and the length of treatment varied between 3 and 148 days. Two infants died associated with severe infection. Liver toxicity was observed in six infants treated with Voriconazole. Therapeutic drug management for Voriconazole was performed in four infants. Target levels were not achieved by the doses that are recommended.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Rare fungal infections, predominantly cutaneous Aspergillosis affects the most immature preterm infants and may cause severe disease. Treatment with Voriconazole has a high rate of liver toxicity and target levels are difficult to achieve in extremely immature infants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003407","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T15:08:52Z","timestamp":1637766532000},"page":"352-357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Molds and More: Rare Fungal Infections in Preterm Infants &lt;24 Weeks of Gestation"],"prefix":"10.1097","volume":"41","author":[{"given":"Katrin","family":"Mehler","sequence":"first","affiliation":[{"name":"Division of Neonatology, Department of Neonatology, Children\u2019s Hospital, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Cornely","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Seifert","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Zweigner","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Hygiene, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Janssen","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Neonatology, Children\u2019s Hospital, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Oberthuer","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Neonatology, Children\u2019s Hospital, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/archdischild-2018-316770","article-title":"Active perinatal care of preterm infants in the German Neonatal Network.","volume":"105","author":"Humberg","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(17)31002-4","article-title":"Neonatal sepsis.","volume":"390","author":"Shane","year":"2017","journal-title":"Lancet"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/siny.2000.0014","article-title":"Clinical consequences of an immature barrier.","volume":"5","author":"Rutter","year":"2000","journal-title":"Semin Neonatol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000242513","article-title":"Development of the epidermis in the newborn.","volume":"49","author":"Evans","year":"1986","journal-title":"Biol Neonate"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s12879-017-2646-8","article-title":"Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature.","volume":"17","author":"Gallais","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/21505594.2016.1237332","article-title":"The vaginal mycobiome: A contemporary perspective on fungi in women\u2019s health and diseases.","volume":"8","author":"Bradford","year":"2017","journal-title":"Virulence"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jamapediatrics.2016.0207","article-title":"Survival among infants born at 22 or 23 weeks\u2019 gestation following active prenatal and postnatal care.","volume":"170","author":"Mehler","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"suppl 1","key":"R9-20250615","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00006454-199605000-00018","article-title":"Cutaneous aspergillosis in a neonate.","volume":"15","author":"Gupta","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4049\/jimmunol.1900941","article-title":"Extremely preterm infants have significant alterations in their conventional T cell compartment during the first weeks of life.","volume":"204","author":"Qazi","year":"2020","journal-title":"J Immunol"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fped.2017.00023","article-title":"Age-appropriate functions and dysfunctions of the neonatal neutrophil.","volume":"5","author":"Lawrence","year":"2017","journal-title":"Front Pediatr"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4049\/jimmunol.1501811","article-title":"Human neutrophils use different mechanisms to kill Aspergillus fumigatus Conidia and Hyphae: evidence from Phagocyte defects.","volume":"196","author":"Gazendam","year":"2016","journal-title":"J Immunol"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/jof7020070","article-title":"Dexamethasone promotes Aspergillus fumigatus growth in macrophages by triggering M2 repolarization via targeting PKM2.","volume":"7","author":"Luvanda","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/JCM.43.8.3925-3931.2005","article-title":"Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity.","volume":"43","author":"Mennink-Kersten","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children.","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2165\/00003495-198938020-00004","article-title":"Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.","volume":"38","author":"Lackner","year":"1989","journal-title":"Drugs"},{"issue":"suppl 2","key":"R21-20250615","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0378-3782(12)70024-5","article-title":"Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates.","volume":"88","author":"Manzoni","year":"2012","journal-title":"Early Hum Dev"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/08880018.2015.1088905","article-title":"The clinical significance of voriconazole therapeutic drug monitoring in children with invasive fungal infections.","volume":"32","author":"Kang","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkw056","article-title":"Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre.","volume":"71","author":"Boast","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/phar.1829","article-title":"An optimized voriconazole dosing strategy to achieve therapeutic serum concentrations in children younger than 2 years old.","volume":"36","author":"Zembles","year":"2016","journal-title":"Pharmacotherapy"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.jp.7211532","article-title":"Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.","volume":"26","author":"Frankenbusch","year":"2006","journal-title":"J Perinatol"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial.","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jpids\/piu074","article-title":"A prospective, international cohort study of invasive mold infections in children.","volume":"4","author":"Wattier","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.arcped.2010.04.012","article-title":"[Primary cutaneous aspergillosis complicated with invasive aspergillosis in an extremely preterm infant: case report and literature review].","volume":"17","author":"Stock","year":"2010","journal-title":"Arch Pediatr"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhin.2011.06.012","article-title":"Investigation of a cluster of cutaneous aspergillosis in a neonatal intensive care unit.","volume":"79","author":"Etienne","year":"2011","journal-title":"J Hosp Infect"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1128\/JCM.38.10.3612-3618.2000","article-title":"Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit.","volume":"38","author":"James","year":"2000","journal-title":"J Clin Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:04:27Z","timestamp":1750003467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003407","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}